期刊文献+

健脾解毒方逆转大肠癌多药耐药基因的研究 被引量:6

multidrug resistance gene of cancer of colon reversed by Jianpijiedu Herb
下载PDF
导出
摘要 目的从分子生物学的角度探讨健脾解毒方逆转大肠癌多药耐药基因的作用机制,为中医健脾解毒法治疗大肠癌提供理论依据。方法应用健脾解毒方药对SD大鼠进行灌胃,采集动脉血制备健脾解毒方药物血清,在体外培养人结肠直肠腺癌耐长春新碱细胞HCT-8/V,分别加入培养液配制的5%、10%、15%、20%健脾解毒方药物血清,采用MTT方法检测各组HCT-8/V细胞生长抑制率。结果健脾解毒方药物血清对HCT-8/V细胞有抑制作用,随浓度升高、时间延长,其抑制作用增强,呈剂量和时间效应关系。20%的药物血清和VCR在24、48、72 h对肿瘤细胞的生长抑制率均有统计学差异(P<0.01),随作用时间延长,对肿瘤细胞的杀伤作用明显增强。结论健脾解毒方可逆转大肠癌多药耐药基因,并伴随相关基因的调控。 To investigate the mechanism of Jianpijiedu herb reversing muhidrug resistance gene of cancer of colon, and to provide a theoretical basis for treatment of colorectal cancer. Methods The drug serum of Jianpijiedu Herb was prepared with SD rats. HCT-8/V cells were cultured in vitro. HCT-8/V cells growth inhibition with 5% , 10%, 15% and 20% of the drug serum was measured by MTI" method. Results Jianpijiedu herb inhibited HCT-8/V cell growth in a timeand dosedependent manner. The inhibition of cell growth rates were significantly different with 20% of the drug serum of Jianpijiedu Herb and VCR by 24 h, 48 h and 72 h ( P 〈 0.01 ). The killing effect on tumor cells was significantly enhanced with prolongeel time. Conclusion Jianpijiedu herb might reverse multidrug resistance gene of cancer of colon in the control of related gene.
出处 《山东医药》 CAS 2012年第1期19-21,共3页 Shandong Medical Journal
基金 上海市卫生局科研课题计划项目(2006116)
关键词 肠肿瘤 健脾解毒方 基因 MDR intestinal neoplasms Jianpijiedu herb genes, MDR
  • 相关文献

参考文献10

  • 1Kunnimalaiyaan M,Ndiaye M,Chen H.Apoptosis-mediated medul-lary thyroid cancer growth suppression by the PI3K inhibitorLY294002[J].Surgery,2010,140(6):1009-1014.
  • 2周园园,孙艳芹,郭琳琅.小细胞肺癌阿霉素多药耐药细胞模型的建立及其与Bcl-2家族蛋白表达的关系[J].山东医药,2009,49(3):31-34. 被引量:3
  • 3Westfall SD,Skinner MK.Inhibition of phosphatidylinositol 3-ki-nase sensitizes ovarian cancer cells to carboplatin and allows adjunctchemotherapy treatment[J].Molecular Cancer Therapentics,2008,4(11):1764-1771.
  • 4Lu B,Shioohar ET,Edwards E,et al.The use of tyrosine kinaseinhibitors in modifying the response of tumor microvasculature to ra-diotherapy[J].Technology in Cancer Research Treatment,2005,4(6):691-698.
  • 5Yamaguchi K,Lee SH,Kim JS,et al.Activating transcription fac-tor 3 and early growth response 1 are the novel targets of LY294002in a phosphatidylinositol 3-kinase-independent pathway[J].CancerResearch,2006,66(4):2376-2384.
  • 6Pawar PL,Nabar BM.Effect of plant extracts formulated in differentointment bases on MDR strains[J].Indian J Pharm Sci,2010,72(3):397-401.
  • 7Dey S,Guha M,Alam A,et al.Malarial infection develops mito-chondrial pathology and mitochondrial oxidative stress to promotehepatocyte apoptosis[J].Free radical biology&medicine,2009,46(2):271-281.
  • 8Takara K,Sakaeda T,Okumura K.An update on overcomingMDR1-mediated multidrug resistance in cancer chemotherapy[J].Curr Pharm Des,2009,12(3):273-286.
  • 9Boca M,Distefano G,Qian F,et al.Polycystin-1 Induces Resist-ance to Apoptosis through the Phosphatidylinositol 3-Kinase/Akt Sig-naling Pathway[J].Journal of the American society of nephrology,2006,17(3):637-647.
  • 10Lu Y,Jiao R,Chen X,et al.Methylene blue-mediated photody-namic therapy induces mitochondria-dependent apoptosis in HeLacell[J].Journal of cellular biochemistry,2008,10(5):1451-1460.

二级参考文献7

共引文献2

同被引文献111

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部